Growing evidence has shown that systemic inflammatory mediators such as superoxide dismutase (SOD) and lipoprotein-associated phospho-lipase A2 (Lp-PLA2) are associated with CSVD and cognitive impairment [4, 6-8]. The gene discussed is SOD1; the disease is Cognitive impairment.